Journal
ULTRASOUND IN MEDICINE AND BIOLOGY
Volume 35, Issue 8, Pages 1397-1404Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.ultrasmedbio.2009.03.004
Keywords
Photodynamic therapy; Light; Ultrasound; Atomic force microscopy; Reactive oxygen species
Funding
- Ministry of Education, Youth and Sports of the Czech Republic [MSM 6198959216, 1M61989559201]
- Czech Science Foundation [202/09/1151]
Ask authors/readers for more resources
Photodynamic therapy is a mortality of treatment for tumors. The photochemical interactions of sensitizer, light and molecular oxygen produce reactive oxygen species (ROS) such as singlet oxygen, peroxide, hydroxyl radical and superoxide ion. The tumor is destroyed either by the formation of highly reactive singlet oxygen (type II mechanism) or by the formation of radical products (type I mechanism) generated in an energy transfer reaction. The resulting damage to organelles within malignant cells leads to tumor ablation. The cellular effects include membrane damage, mitochondrial damage and DNA damage. A new treatment modality called sonodynamic therapy has been developed, in which the ultrasound-induced cytotoxicity of sonochemical sensitizers inhibits tumor growth. In this study, the promising new, generation of sensitizers - phthalocyanines - were used to induce the photodamage. In addition, we applied an ultrasound treatment to support the photodynamic effect. We report on the production of ROS in G361 melanoma cells. Light-emitting diodes were used to evoke the photodynamic effect. Changes in cells were evaluated using fluorescence microscope and atomic force microscopy. The quantitative ROS production changes in relation to sensitizer concentration, irradiation doses and ultrasound intensity were proved by a fluororeader. Our results showed the highest generation of ROS within G361 melanoma cells was achieved at an irradiation dose of 15 Jcm(-2) followed by ultrasound treatment at intensity of 2 Wcm(-2) and frequency of 1 MHz in the presence of 100 mu M chloroaluminum phthalocyanine disulfonate (CIAIPcS(2)). These results suggest that ClAlPcS, is a potential photosensitizer and sonosensitizer for sonodynamic or photodynamic treatment of cancer. (E-mail: kol@tunw.upol.cz) (C) 2009 World Federation for Ultrasound ill Medicine & Biology.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available